oncology innovation

J&J Acquires Halda to Advance Next-Gen Oral Cancer Drugs

NEW BRUNSWICK, N.J., Dec. 29, 2025 — Johnson & Johnson has completed the acquisition of Halda Therapeutics, bringing in...

By cGxPwire Editor
December 29, 2025

Pharma

Peptinovo Advances Targeted Chemotherapy Manufacturing

ANN ARBOR, Mich., Dec. 17, 2025 — Peptinovo Biopharma, in collaboration with Chemelectiva S.r.l., announced a breakthrough manufacturing and...

By cGxPwire Editor
December 18, 2025

Bio-Pharma

Greenwich Reports 80% Recurrence Reduction in FLAMINGO-01

STAFFORD, Texas — December 15, 2025 — Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, announced a preliminary analysis from...

By cGxPwire Editor
December 15, 2025

MedTech

Renovo Rx Showcases Targeted Oncology Innovation at MedTech Forum

MOUNTAIN VIEW, Calif., November 4, 2025 — RenovoRx, Inc. (NASDAQ: RNXT), a life sciences company pioneering targeted oncology therapies...

By cGxPwire Editor
November 5, 2025

Bio-Pharma

Phio Pharmaceuticals Strengthens Governance with New Lead Director

King of Prussia, Pennsylvania – October 31, 2025 — Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biopharmaceutical company developing...

By cGxPwire Editor
October 31, 2025

Find Jobs Across Pharma, Biotech & Life Sciences

Discover verified job opportunities from top companies worldwide. Apply easily and grow your career in the life sciences industry.

Bio-Pharma

BBOT Showcases Novel RAS:PI3Kα Breaker at SABCS 2025

South San Francisco, Calif. – October 30, 2025 — BridgeBio Oncology Therapeutics, Inc. (BBOT) announced two poster presentations at...

By cGxPwire Editor
October 31, 2025

.Clinical Bio-Pharma

Adcendo Secures FDA Fast Track for ADCE-D01 Targeting Soft Tissue Sarcoma

COPENHAGEN, Denmark, Oct. 9, 2025 – (cGxP.wire) – Adcendo ApS, a biotechnology company pioneering first- and best-in-class antibody-drug conjugates...